TrialClinical and molecular hepatology2016

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study).

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.